Grisanti Capital Management LLC held its position in Cigna Corporation (NYSE:CI) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,740 shares of the health services provider’s stock at the end of the second quarter. Grisanti Capital Management LLC’s holdings in Cigna Corporation were worth $458,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. BlackRock Inc. boosted its position in shares of Cigna Corporation by 2,335.5% in the first quarter. BlackRock Inc. now owns 16,987,425 shares of the health services provider’s stock worth $2,488,489,000 after buying an additional 16,289,943 shares in the last quarter. Vanguard Group Inc. boosted its position in shares of Cigna Corporation by 3.5% in the first quarter. Vanguard Group Inc. now owns 16,706,266 shares of the health services provider’s stock worth $2,447,301,000 after buying an additional 570,241 shares in the last quarter. State Street Corp boosted its position in shares of Cigna Corporation by 1.7% in the first quarter. State Street Corp now owns 11,137,018 shares of the health services provider’s stock worth $1,631,451,000 after buying an additional 190,323 shares in the last quarter. Wellington Management Group LLP boosted its position in shares of Cigna Corporation by 9.3% in the first quarter. Wellington Management Group LLP now owns 10,765,751 shares of the health services provider’s stock worth $1,577,075,000 after buying an additional 913,991 shares in the last quarter. Finally, Boston Partners boosted its position in shares of Cigna Corporation by 3.1% in the first quarter. Boston Partners now owns 3,604,693 shares of the health services provider’s stock worth $528,052,000 after buying an additional 108,880 shares in the last quarter. 86.91% of the stock is currently owned by institutional investors and hedge funds.

Cigna Corporation (NYSE CI) opened at 174.38 on Friday. Cigna Corporation has a 52 week low of $115.03 and a 52 week high of $178.57. The company has a market capitalization of $43.91 billion, a price-to-earnings ratio of 20.12 and a beta of 0.46. The firm has a 50-day moving average price of $172.22 and a 200-day moving average price of $159.17.

Cigna Corporation (NYSE:CI) last announced its quarterly earnings data on Friday, August 4th. The health services provider reported $2.91 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.48 by $0.43. Cigna Corporation had a return on equity of 17.40% and a net margin of 7.46%. The business had revenue of $10.32 billion for the quarter, compared to the consensus estimate of $10.26 billion. During the same period in the previous year, the business earned $1.98 earnings per share. The business’s revenue was up 3.6% on a year-over-year basis. Analysts anticipate that Cigna Corporation will post $10.02 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Grisanti Capital Management LLC Has $458,000 Stake in Cigna Corporation (NYSE:CI)” was originally posted by TheOlympiaReport and is the property of of TheOlympiaReport. If you are reading this report on another site, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://theolympiareport.com/2017/08/12/grisanti-capital-management-llc-has-458000-stake-in-cigna-corporation-nyseci.html.

A number of brokerages have recently commented on CI. Jefferies Group LLC reaffirmed a “buy” rating and set a $190.00 price target (down previously from $199.00) on shares of Cigna Corporation in a research report on Friday, August 4th. Zacks Investment Research cut Cigna Corporation from a “buy” rating to a “hold” rating in a research report on Tuesday. Royal Bank Of Canada reaffirmed a “buy” rating and set a $185.00 price target on shares of Cigna Corporation in a research report on Wednesday. ValuEngine cut Cigna Corporation from a “buy” rating to a “hold” rating in a research report on Thursday, July 20th. Finally, BidaskClub cut Cigna Corporation from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three equities research analysts have rated the stock with a hold rating and eighteen have given a buy rating to the company. Cigna Corporation has an average rating of “Buy” and an average price target of $180.06.

In other news, CEO David Cordani sold 153,168 shares of Cigna Corporation stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $170.20, for a total value of $26,069,193.60. Following the sale, the chief executive officer now directly owns 421,162 shares of the company’s stock, valued at $71,681,772.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Nicole S. Jones sold 20,312 shares of Cigna Corporation stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $160.04, for a total value of $3,250,732.48. Following the completion of the sale, the executive vice president now directly owns 44,737 shares in the company, valued at $7,159,709.48. The disclosure for this sale can be found here. Insiders sold 261,539 shares of company stock worth $44,527,348 over the last ninety days. Insiders own 1.30% of the company’s stock.

Cigna Corporation Company Profile

Cigna Corporation (Cigna), together with its subsidiaries, is a health services company. The Company offers medical, dental, disability, life and accident insurance and related products and services. The Company’s segments include Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations and Corporate.

Institutional Ownership by Quarter for Cigna Corporation (NYSE:CI)

Receive News & Ratings for Cigna Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.